Related Experiment Video
Updated: Jan 7, 2026

08:32
Flow Cytometric Analysis of Extracellular Vesicles from Cell-conditioned Media
Published on: February 12, 2019
14.3K
Extracellular Vesicles in Cardiac Cell Crosstalk: from Intercellular Communication to Clinical Translation.
Rahul Sanwlani1, Patrizia Camelliti2
1Faculty of Health and Medical Sciences, School of Biosciences, University of Surrey, Guildford, Surrey, GU2 7XH, United Kingdom. rs0093@surrey.ac.uk.
Cardiovascular Drugs and Therapy
|December 18, 2025
Summary
Extracellular vesicles (EVs) are key to heart cell communication, influencing cardiac repair and disease. This review synthesizes EV roles and explores their potential as cardiovascular disease biomarkers and therapeutics.
Area of Science:
- Cardiovascular Biology
- Cellular Communication
- Biomaterials Science
Background:
- Cardiovascular disease (CVD) is a major global health burden.
- Intercellular communication is vital for cardiac homeostasis and stress adaptation.
- Extracellular vesicles (EVs) mediate communication by transporting bioactive molecules.
Purpose of the Study:
- To synthesize EV-mediated crosstalk in the heart from various cell sources.
- To explore the translational potential of cardiac EVs as biomarkers and therapeutics.
- To evaluate challenges and propose a roadmap for clinical translation of cardiac EVs.
Main Methods:
- Systems-level synthesis of existing literature on cardiac EVs.
- Integration of evidence from cardiomyocyte- and non-cardiomyocyte-derived EVs.
- Critical evaluation of technical and regulatory barriers for clinical translation.
Main Results:
- EVs from diverse cardiac cells orchestrate signalling networks influencing cardiac remodelling and injury response.
- Cardiac EVs show promise as diagnostic and prognostic biomarkers.
- Emerging therapeutic and bioengineering strategies utilizing cardiac EVs are discussed.
Conclusions:
- EV-mediated crosstalk is fundamental to cardiac function and disease progression.
- Cardiac EVs hold significant translational potential for cardiovascular medicine.
- Overcoming technical and regulatory hurdles is crucial for advancing EV-based diagnostics and therapeutics.

